Recovery of kidney function following delayed use of theralite™ dialyzer in a patient with myeloma cast nephropathy

Khagendra Dahal, Shani Shastri, Uma Narayanasami, Vanesa Bijol, Karen Rider, James A. Strom, Bertrand L. Jaber

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We report the case of a 60- year- old man who presented with newly diagnosed multiple myeloma complicated by biopsy-proven acute cast nephropathy, requiring hemodialysis, plasmapheresis and chemotherapy. After remaining dialysis dependent for 5 weeks, a high cut-off (HCO) dialyzer, intended to use for the removal of plasma substances with a molecular weight of up to 45 kDa such as free light chains, was introduced to his outpatient 4-hour hemodialysis regimen with an increase in treatment frequency to 4 sessions per week. Following 6 weeks of dialysis with the HCO dialyzer, serum levels of free κ light chains declined by more than 75%. Concurrently, he recovered kidney function and discontinued dialysis. He subsequently received a successful autologous stem-cell transplant. We discuss the potential merit of using the HCO dialyzer late in the course of the care of patients with myeloma cast nephropathy who are dialysis dependent.

Original languageEnglish (US)
Pages (from-to)318-322
Number of pages5
JournalClinical Nephrology
Volume79
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Recovery of Function
Dialysis
Kidney
Renal Dialysis
Light
Plasmapheresis
Multiple Myeloma
Patient Care
Outpatients
Stem Cells
Molecular Weight
Transplants
Biopsy
Drug Therapy
Serum
Therapeutics

Keywords

  • Acute kidney injury
  • Cast nephropathy
  • Hemodialysis
  • High cut-off dialyzer
  • Myeloma
  • Theralite

ASJC Scopus subject areas

  • Nephrology

Cite this

Recovery of kidney function following delayed use of theralite™ dialyzer in a patient with myeloma cast nephropathy. / Dahal, Khagendra; Shastri, Shani; Narayanasami, Uma; Bijol, Vanesa; Rider, Karen; Strom, James A.; Jaber, Bertrand L.

In: Clinical Nephrology, Vol. 79, No. 4, 04.2013, p. 318-322.

Research output: Contribution to journalArticle

Dahal, Khagendra ; Shastri, Shani ; Narayanasami, Uma ; Bijol, Vanesa ; Rider, Karen ; Strom, James A. ; Jaber, Bertrand L. / Recovery of kidney function following delayed use of theralite™ dialyzer in a patient with myeloma cast nephropathy. In: Clinical Nephrology. 2013 ; Vol. 79, No. 4. pp. 318-322.
@article{dd5b081a6517402990090718f2d73fbc,
title = "Recovery of kidney function following delayed use of theralite™ dialyzer in a patient with myeloma cast nephropathy",
abstract = "We report the case of a 60- year- old man who presented with newly diagnosed multiple myeloma complicated by biopsy-proven acute cast nephropathy, requiring hemodialysis, plasmapheresis and chemotherapy. After remaining dialysis dependent for 5 weeks, a high cut-off (HCO) dialyzer, intended to use for the removal of plasma substances with a molecular weight of up to 45 kDa such as free light chains, was introduced to his outpatient 4-hour hemodialysis regimen with an increase in treatment frequency to 4 sessions per week. Following 6 weeks of dialysis with the HCO dialyzer, serum levels of free κ light chains declined by more than 75{\%}. Concurrently, he recovered kidney function and discontinued dialysis. He subsequently received a successful autologous stem-cell transplant. We discuss the potential merit of using the HCO dialyzer late in the course of the care of patients with myeloma cast nephropathy who are dialysis dependent.",
keywords = "Acute kidney injury, Cast nephropathy, Hemodialysis, High cut-off dialyzer, Myeloma, Theralite",
author = "Khagendra Dahal and Shani Shastri and Uma Narayanasami and Vanesa Bijol and Karen Rider and Strom, {James A.} and Jaber, {Bertrand L.}",
year = "2013",
month = "4",
doi = "10.5414/CN107357",
language = "English (US)",
volume = "79",
pages = "318--322",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "4",

}

TY - JOUR

T1 - Recovery of kidney function following delayed use of theralite™ dialyzer in a patient with myeloma cast nephropathy

AU - Dahal, Khagendra

AU - Shastri, Shani

AU - Narayanasami, Uma

AU - Bijol, Vanesa

AU - Rider, Karen

AU - Strom, James A.

AU - Jaber, Bertrand L.

PY - 2013/4

Y1 - 2013/4

N2 - We report the case of a 60- year- old man who presented with newly diagnosed multiple myeloma complicated by biopsy-proven acute cast nephropathy, requiring hemodialysis, plasmapheresis and chemotherapy. After remaining dialysis dependent for 5 weeks, a high cut-off (HCO) dialyzer, intended to use for the removal of plasma substances with a molecular weight of up to 45 kDa such as free light chains, was introduced to his outpatient 4-hour hemodialysis regimen with an increase in treatment frequency to 4 sessions per week. Following 6 weeks of dialysis with the HCO dialyzer, serum levels of free κ light chains declined by more than 75%. Concurrently, he recovered kidney function and discontinued dialysis. He subsequently received a successful autologous stem-cell transplant. We discuss the potential merit of using the HCO dialyzer late in the course of the care of patients with myeloma cast nephropathy who are dialysis dependent.

AB - We report the case of a 60- year- old man who presented with newly diagnosed multiple myeloma complicated by biopsy-proven acute cast nephropathy, requiring hemodialysis, plasmapheresis and chemotherapy. After remaining dialysis dependent for 5 weeks, a high cut-off (HCO) dialyzer, intended to use for the removal of plasma substances with a molecular weight of up to 45 kDa such as free light chains, was introduced to his outpatient 4-hour hemodialysis regimen with an increase in treatment frequency to 4 sessions per week. Following 6 weeks of dialysis with the HCO dialyzer, serum levels of free κ light chains declined by more than 75%. Concurrently, he recovered kidney function and discontinued dialysis. He subsequently received a successful autologous stem-cell transplant. We discuss the potential merit of using the HCO dialyzer late in the course of the care of patients with myeloma cast nephropathy who are dialysis dependent.

KW - Acute kidney injury

KW - Cast nephropathy

KW - Hemodialysis

KW - High cut-off dialyzer

KW - Myeloma

KW - Theralite

UR - http://www.scopus.com/inward/record.url?scp=84877318286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877318286&partnerID=8YFLogxK

U2 - 10.5414/CN107357

DO - 10.5414/CN107357

M3 - Article

C2 - 22541683

AN - SCOPUS:84877318286

VL - 79

SP - 318

EP - 322

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 4

ER -